906093-30-9 Usage
Uses
Used in Pharmaceutical Synthesis:
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)(acetate) is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic benefits. Its unique structure and properties allow for the creation of compounds that can address specific medical needs.
Used in Fine Chemicals Production:
In the fine chemicals industry, Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)(acetate) serves as a key component in the production of specialty chemicals. Its versatility and reactivity make it suitable for creating a variety of high-value compounds used in various applications, including fragrances, dyes, and other specialty products.
Used in Medical Research and Development:
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)(acetate) is utilized in medical research and development as a potential active pharmaceutical ingredient. Its pharmacological properties are being explored for the treatment of various medical conditions, making it a valuable asset in the search for new therapeutic agents.
Overall, Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)(acetate) is a versatile chemical compound with a wide range of applications in the pharmaceutical, fine chemicals, and medical research industries. Its unique structure, enhanced solubility, and stability contribute to its potential as a promising candidate for the development of new drugs and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 906093-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,0,9 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 906093-30:
(8*9)+(7*0)+(6*6)+(5*0)+(4*9)+(3*3)+(2*3)+(1*0)=159
159 % 10 = 9
So 906093-30-9 is a valid CAS Registry Number.
906093-30-9Relevant articles and documents
For the preparation of pyrazole derivatives
-
Paragraph 0128-0130, (2017/02/24)
The present invention provides a prolinamide compound useful as a drug or the like and an industrially advantageous method for producing a piperazinyl pyrazole compound that is a production intermediate of the prolinamide compound. Specifically, the invention is a method for producing a compound represented by general formula (1) as represented by the following formula (where the symbols in the formula are the same as defined in the specification) or a salt thereof, wherein a compound represented by general formula (2) is produced, a pyrazole ring being formed via a reaction between a compound represented by general formula (3) and phosphorus pentasulfide; and, once the compound represented by general formula (2) is deprotected, a carboxylate of a compound represented by general formula (6) is produced, the compound obtained by forming a carboxylic acid and a salt.
Process for the preparation of teneligliptin
-
Page/Page column 26; 27, (2017/01/02)
A process for the preparation of teneligliptin.
PROCESS FOR THE PREPARATION OF 1-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZINE
-
, (2015/02/25)
The present invention provides a process for the preparation of 1-(3-methyl-1- phenyl-1H-pyrazol-5-yl)piperazine of Formula (III), or salts thereof. The invention also provides a process for the preparation of {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl]pyrrolidin-2-yl}(1,3-thiazolidin-3-yl)methanone, or salts thereof, using 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine of Formula (III), or salts thereof.
